|
|
VANCOUVER, BC / ACCESSWIRE / April 26, 2022 / Telescope Innovations Corp. "Telescope" or the "Company" CSE:TELI, a chemical technology company, announces that in connection with the Companys annual general meeting of shareholders scheduled to occur on April 28, 2022, management of the Company understands that a nomination from the floor will be made for the election of Henry... Lire le communiqué |
|
| |
|
| |
|
|
VANCOUVER, BC / ACCESSWIRE / April 25, 2022 / Telescope Innovations Corp. "Telescope" or the "Company" CSE:TELI, a chemical technology company, announces the creation of "Telescope Industries", a branch of the Company dedicated to resolving process and manufacturing inefficiencies in the chemical industry. For its first project, Telescope Industries has been engaged... Lire le communiqué |
|
| |
|
| |
|
|
VANCOUVER, BC / ACCESSWIRE / March 14, 2022 / Telescope Innovations Corp. "Telescope" or the "Company" CSE:TELI, a chemical technology company, announces it has engaged Translational Life Sciences Inc. "TLS" to evaluate the potential therapeutic effects of Telescopes proprietary, psilocybinlike novel chemical entities "NCEs".TLS performs high thr... Lire le communiqué |
|
| |
|
| |
|
|
VANCOUVER, BC / ACCESSWIRE / March 1, 2022 / Telescope Innovations Corp. "Telescope" or the "Company" CSE:TELI, a chemical technology company, is pleased to provide a corporate update summarizing the significant milestones the Company has achieved over the past year of operations. The rapidly growing Company has delivered on the following three milestones that it believes set... Lire le communiqué |
|
| |
|
| |
|
|
VANCOUVER, BC / ACCESSWIRE / January 17, 2022 / Telescope Innovations Corp. "Telescope" or the "Company" CSE:TELI announces that it has filed a Patent Cooperation Treaty "PCT" patent application for its scalable manufacturing methods to produce psilocybin and related tryptamine compounds. This application claims the priority date of a preceding provisional... Lire le communiqué |
|
| |
|
| |
